Incyte Corporation logo

Incyte Corporation

NASDAQ:INCY

Overview | Financials
Company Name Incyte Corporation
Symbol INCY
Currency USD
Price 80.58
Market Cap 15,523,737,000
Dividend Yield 0%
52-week-range 50.35 - 83.95
Industry Biotechnology
Sector Healthcare
CEO Mr. Herve Hoppenot
Website https://www.incyte.com

An error occurred while fetching data.

About Incyte Corporation

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various

Related Stocks

ICON Public Limited Company logo

ICON Public Limited Company

ICLR

212.27 USD

Alnylam Pharmaceuticals, Inc. logo

Alnylam Pharmaceuticals, Inc.

ALNY

268.95 USD

Insulet Corporation logo

Insulet Corporation

PODD

275.1 USD

Hologic, Inc. logo

Hologic, Inc.

HOLX

79.76 USD

BioMarin Pharmaceutical Inc. logo

BioMarin Pharmaceutical Inc.

BMRN

66.13 USD

Viatris Inc. logo

Viatris Inc.

VTRS

12.93 USD

Bio-Techne Corporation logo

Bio-Techne Corporation

TECH

74.41 USD

Financials

Numbers are in millions USD

Numbers are in millions USD